Private Equity

US

Hospitality brand Sonder pockets $170m Series E

Sonder, a San Francisco- and Montreal-based hospitality brand, has closed US$170 million in Series E financing, according to a blog post.

1 min read · 24 June 2020

Cape Privacy snaps up seed funding led by Boldstart, Version One

New York City-based Cape Privacy, a privacy platform for collaborative data science and machine learning, has secured US$5 million in seed funding.

1 min read · 24 June 2020

Cyclica nets C$23m in Drive Capital-led Series B round

Cyclica, a Toronto-based artificial intelligence-enabled platform that supports drug discovery, has raised C$23 million in Series B financing.

3 min read · 24 June 2020

VC-backed Repare Therapeutics closes Nasdaq IPO, raises $253m

Repare Therapeutics, a Boston- and Montreal-based precision oncology company, has closed its initial public offering on the NASDAQ.

2 min read · 24 June 2020

OMERS Ventures leads funding round for Landed

San Francisco-based Landed, a residential real estate startup, has secured US$10.5 million in funding.

1 min read · 24 June 2020

Winnipeg's Librestream snags C$24m Series D led by CBGF

Winnipeg, Manitoba-based Librestream, a provider of augmented worker enterprise solutions, has raised C$24 million in Series D funding.

1 min read · 24 June 2020

Tribe Capital leads funding round for HR platform Humi

Humi, a Toronto-based human resources, payroll, and benefits solution for small and medium-sized businesses, has secured C$15 million in equity and debt financing.

3 min read · 23 June 2020

Sana Biotechnology picks up $700m in VC financing

Sana Biotechnology, a Seattle, Washington-based company focused on creating and delivering engineered cells as medicines, has raised more than US$700 million.

2 min read · 23 June 2020

SCERS re-ups with Summit following strong overall VC performance

The pension committed $20m to Summit Partners Venture Capital Fund V and saw its venture portfolio post a 21.27% return in Q4 2019.

2 min read · 22 June 2020

VC-backed Repare Therapeutics goes public, raises $220m

Repare Therapeutics, a Boston- and Montreal-based precision oncology company, has raised about US$220 million for its IPO after pricing its 11 million shares at US$20 per share.

3 min read · 19 June 2020

Showing 2,021 to 2,030 of 41,791 results
1…202204…1000